IRCT20190706044111N30招募中Unknown
Bioequivalence study of VITALOPHAGE 1000mg tablet of Vitabiotics Pharmed Co., IRAN in comparison of CARBOPHAGE XR 1000mg tablet of Merck in 24 healthy adult subjects under fasting condition
Vitabiotix Pharmed0 个研究点目标入组 24 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 50 years（—）
- 性别
- All
入选标准
- •Aged between 18 - 50 years
- •- Body weight between 50 – 100 kg
- •- Having good health on the basis of medical history and physical & clinical examination
- •- Understand the procedures and give written informed consent
排除标准
- •Subject had undergone surgery of the gastro-intestinal tract
- •Subject had donated a unit of blood or participated in another clinical trial, within the last two months before the first treatment.
- •Subject had a history of drug or alcohol abuse.
- •Subject who smokes more than 10 cigarettes per day.
- •Subject had used any prescription medication within 14 days, or any non-prescription medication within 7 days, before the first treatment.
研究者
相似试验
尚未招募
Unknown
Bioequivalence study of VITALOPHAGE 500mg tablet of Vitabiotics Pharmed Co., IRADiabetes.Long term (current) use of oral hypoglycemic drugsZ79. 84IRCT20190706044111N31Vitabiotix Pharmed24
已完成
不适用
Bioequivalence study of valacyclovir 1000 mg tabletBioequivalence study of valacyclovir 1000 mg tablet (Iran Hormone) versus VALTREX ® 1000 mg (GlaxoSmithKline) Tablet in healthy volunteers.IRCT20220111053692N2Iran Hormone pharmaceutical Co.24
招募中
不适用
Bioequivalence study of valacyclovir 1000 mg tablet (Avicenna) versus VALTREX ® 1000 mg (GlaxoSmithKline) Tablet in healthy volunteersIRCT20220111053692N1Avicenna pharmaceutical Co.24
招募中
Unknown
Investigating the in vivo bioequivalence of Valacyclovir tabletIRCT20220211053992N9Tabriz University of Medical Sciences24
招募中
Unknown
Bioequivalence study of dapagliflozin 10 mg tabletIRCT20230222057495N18Viana Darou Sanat Pharmaceutical company24